Nancy Miller-Rich

Nancy Miller-Rich is currently a Non-executive Director at UDG Healthcare. Prior to this, they were with Intercept Pharmaceuticals, TB Alliance, and Merck. Nancy has over 25 years of experience in the pharmaceutical industry, including stints in global human health business development & licensing, strategy and commercial. Nancy has closed approximately 300 deals producing $10B of value creation and has led digital transformation teams. Nancy is also an advisor and board member for Aurora Bio and Ten63 Therapeutics, and the founder of Miller-Rich Associates.